Journal Watch 9/08/2023Welcome to our weekly round-up of the latest bariatric and obesity-related papers published in the medical literature. As ever, we have...
SELECT trial: Semaglutide reduces the risk of MACE by 20% in adults with overweight or obesityResults from the SELECT cardiovascular outcomes trial has revealed that semaglutide 2.4mg demonstrated a statistically significant and...
Aardvark Therapeutics gains Rare Pediatric Disease Designation for Prader-Willi Syndrome The FDA has granted Aardvark Therapeutics a Rare Pediatric Designation for the use of ARD-101 in Prader-Willi Syndrome (PWS), a rare...
MBX Biosciences gains FDA clearance to study MBX 1416 for post-bariatric hypoglycaemiaMBX Biosciences, a clinical stage biopharmaceutical company developing Precision Endocrine Peptide (PEP) therapeutics to treat an array...
AGA supports reintroduction of bipartisan Treat and Reduce Obesity ActThe American Gastroenterological Association (AGA) has announced support for the reintroduced Treat and Reduce Obesity Act (TROA), which...
Benefits of Tele-CBT for post-bariatric surgery patientsTelephone cognitive behavioural therapy (Tele-CBT) intervention is helpful in reducing symptoms of depression, anxiety, binge eating and...
Tirzepatide found to reduce body weight regardless of duration of condition and BMI before treatment4 days ago